We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Handheld Lab to Enable Faster, Cheaper Point-of-Need Bacterial Infection Identification

By LabMedica International staff writers
Posted on 30 Nov 2022

Antimicrobial resistance (AMR) is the unresponsiveness of bacteria to a certain antibiotic due to mutations or resistance genes the species has gained. More...

This is a natural process, however, with the copious amounts of antibiotics that are used, this process is highly accelerated and becomes a danger to our healthcare system. For most people, treatment for bacterial infections is based merely on symptoms, which increases the chance of misdiagnosis and prolonged disease course. Now, instant, accessible, reliable testing for viruses and bacteria will be soon made possible by the world’s smallest portable bacteria identification lab that uses cloud-based, machine learning algorithms to identify bacterial species in five minutes, without the need for expert users or expensive lab infrastructure.

Nostics B.V. (Amsterdam, The Netherlands) is taking spectroscopy where it has never been before: bacterial identification. By combining spectroscopy with nanotechnology and advanced AI classification, the company will soon launch a novel diagnostic tool for point-of-care (PoC) bacterial infection identification. The new digital diagnostics platform from Nostics can provide fast and accurate diagnostics for bacterial infections without the need for costly labs.

The Nostics PoC solution can fit in a backpack, making diagnostics accessible which is the key to combating AMR. By using a handheld device, Raman spectroscopy, cutting-edge nanosurfaces and advanced AI algorithms, the platform has the potential to change the lives of people in places without access to bacterial diagnostics and accelerate this access in countries with more developed healthcare facilities.

Related Links:
Nostics B.V.


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Staining System
RAL DIFF-QUIK
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Increased polysialic acid in schizophrenia patients represents a potential diagnostic tool and possible target for treatment (Photo courtesy of 123RF)

New Technique for Measuring Acidic Glycan in Blood Simplifies Schizophrenia Diagnosis

Polysialic acid is a unique acidic glycan predominantly found in brain regions associated with memory and emotion, but it is also present in the bloodstream. Research has shown that blood levels of polysialic... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.